M&A | Partnerships

Bioventus entered into a U.S. contract with UnitedHealthcare whereby UH's commercial plan members will have access to DUROLANE and GELSYN-3 to treat knee osteoarthritis pain. 

Ortho Regenerative Technologies entered into an agreement to evaluate a commercial product from an unnamed orthopedic company partner for use with Ortho's Ortho-R biopolymer matrix. 

Onkos Surgical will market Bone Solutions' OsteoCrete® magnesium-based bone void filler under the GenVie brand through a private label agreement.

WishBone Medical entered into a private label distribution agreement with Bone Solutions for worldwide rights to sell OsteoCrete® bone void filler in pediatric applications.

Collagen Matrix, manufacturer of collagen- and mineral-based products for tissue and bone repair and regeneration, was acquired by Linden Capital Partners.